Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest in this topic

  1. What Do Sugar, Gila Monsters, and the Therapeutic Dance Have in Common With GLP-1RA, Stroke, and Dementia? 2026-09-25
  2. Myo-inositol as a spectroscopic marker of neuroinflammation in frontotemporal lobar degeneration 2026-09-20
  3. Laromestrocel preserves brain volume and cognitive function in Alzheimers disease by inhibiting neuroinflammation 2026-09-17

Studies

1,157 studies carry this tag.

Date range

1986 to 2026

Top journals

  • The Journal of biological chemistry 109
  • The Journal of neuroscience : the official journal of the Society for Neuroscience 42
  • Proceedings of the National Academy of Sciences of the United States of America 39
  • Neuron 28
  • Nature 23

363 journals in all.

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Multi-omics integration reveals the role of N6-methyladenosine in epilepsy, ischemic stroke, and vascular dementia

    ✓ Peer-reviewed alzhub usefulness score 34 out of 100. Molecular Brain 2025-07-07 Vascular contributions

    We identified 218 m6A sites significantly associated with the three diseases, highlighting 3,430 associations between m6A sites and gene expression.

  2. Reduction of sphingomyelinase activity associated with progranulin deficiency and frontotemporal dementia

    ✓ Peer-reviewed alzhub usefulness score 40 out of 100. Neurobiology of Disease 2025-07-07 Lewy body dementia

    Loss-of-function mutations affecting the lysosomal protein progranulin are a leading cause of frontotemporal dementia.

  3. Rescue of protein dyshomeostasis in hippocampal astrocytes from an Alzheimer’s disease mouse model by stabilizing ER-mitochondrial interactions at a 20 nm distance

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Alzheimer s Research & Therapy 2025-07-04 Inflammation and the immune system

    Autophagic markers beclin 1, LC3II and p62, and lysosome-related marker cathepsin B, all upregulated in AD astrocytes, were significantly reduced, while autophagic flux was rescued, by stabilizing 20 nm-MERCS.

  4. Saikosaponin C ameliorates tau-related pathology by modulating oxidative stress and MAPK axis in Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 42 out of 100. Journal of Ethnopharmacology 2025-07-02 Disease mechanisms

    It has been demonstrated to have neuroprotective effects in cellular models of neurodegenerative diseases; however, its precise mechanism of action in alleviating tau pathology in Alzheimer's disease (AD), as well as its potential to improve cognitive deficits in animal models, has not yet been elucidated.

  5. Connexin43 hemichannel blockade turns microglia neuroprotective and mitigates cognitive deficits in a mouse model of amyloidosis

    ✓ Peer-reviewed alzhub usefulness score 48 out of 100. Nature Communications 2025-07-01 Inflammation and the immune system

    Alzheimer’s disease (AD), the leading cause of senile dementia, lacks effective therapies.

  6. Enrichment of extracellular vesicles using Mag-Net for the analysis of the plasma proteome

    ✓ Peer-reviewed alzhub usefulness score 56 out of 100. Nature communications 2025-07-01 Digital health tools

    Extracellular vesicles (EVs) in plasma are composed of exosomes, microvesicles, and apoptotic bodies.

  7. Paeoniflorin exercise-mimetic potential regulates the Nrf2/HO-1/BDNF/CREB and APP/BACE-1/NF-κB/MAPK signaling pathways to reduce cognitive impairments and neuroinflammation in amnesic mouse model

    ✓ Peer-reviewed alzhub usefulness score 42 out of 100. Biomedicine & Pharmacotherapy 2025-07-01 Inflammation and the immune system

    Microglia-mediated neuroinflammation plays a crucial role in memory and cognitive deficits and the development of early mild cognitive impairment (MCI) associated with Alzheimer's disease (AD).

  8. Exercise-induced irisin ameliorates cognitive impairment following chronic cerebral hypoperfusion by suppressing neuroinflammation and hippocampal neuronal apoptosis

    ✓ Peer-reviewed alzhub usefulness score 48 out of 100. Journal of Neuroinflammation 2025-06-28 Inflammation and the immune system

    Hippocampal and serum irisin levels were progressively reduced in CCH mice.

  9. Mechanism of heme oxygenase-1 regulation of ferroptosis in vascular dementia

    ✓ Peer-reviewed alzhub usefulness score 37 out of 100. Frontiers in Molecular Neuroscience 2025-06-26 Lewy body dementia

    Vascular dementia (VaD) is a neurodegenerative disorder characterized by chronic oxygen insufficiency, leading to the generation of oxygen-free radicals, inflammatory responses, disturbances in iron metabolism, lipid peroxidation, and other pathological changes that disrupt intracellular homeostasis.

  10. Age‐Related Complement C3 Drives Memory Impairments and Associated Neuropathologies in a Mouse Model

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Aging Cell 2025-06-20 Disease mechanisms

    Aging is the greatest risk factor for learning and memory disorders; dementia prevalence significantly increases with age due to numerous molecular changes in the body.

  11. MCC950 suppresses NLRP3-dependent neuroinflammation and ameliorates cognitive decline in a rat model of cerebral small vessel disease

    ✓ Peer-reviewed alzhub usefulness score 38 out of 100. Neural Regeneration Research 2025-06-19 Inflammation and the immune system

    JOURNAL/nrgr/04.03/01300535-202606000-00056/figure1/v/2026-02-11T151048Z/r/image-tiff Cerebral small vessel disease is a major vascular contributor to cognitive impairment and dementia.

  12. The increase in TDP-43 and neurogranin blood levels at different stages of cognitive impairment in the elderly people: A cross-sectional study

    ✓ Peer-reviewed alzhub usefulness score 39 out of 100. Journal of Alzheimer s Disease 2025-06-16 Brain tissue and pathology

    Aβ 42 , TDP-43, and neurogranin show potential as blood-based biomarkers for cognitive decline and may provide insight into the pathogenesis of neurodegeneration.

  13. A single dose of a vectorized mAb targeting TDP-43 potently inhibits the neuropathology in a model of ALS/FTD

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Molecular Therapy 2025-06-14 Brain tissue and pathology

    Transactive response DNA binding protein-43 (TDP-43)-mediated pathology is a hallmark of devastating neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).

  14. Association of Leucocyte Telomere Length With Stroke, Dementia, and Late-Life Depression

    ✓ Peer-reviewed alzhub usefulness score 57 out of 100. Neurology 2025-06-11 Brain tissue and pathology

    The study included 356,173 participants (median age 56 years; 53.69% female).

  15. Extracellular vesicles in TDP-43 proteinopathies: pathogenesis and biomarker potential

    ✓ Peer-reviewed alzhub usefulness score 45 out of 100. Molecular Neurodegeneration 2025-06-10 Brain tissue and pathology

    Extracellular vesicles (EVs) are membrane-enclosed nanoparticles released by most cell types, and from multiple sub-cellular compartments.

  16. Fluorescence Lifetime-Based FRET Biosensors for Monitoring N Terminal Domain-Dependent Interactions of TDP-43 in Living Cells: A Novel Approach for ALS and FTD Drug Discovery

    ✓ Peer-reviewed alzhub usefulness score 38 out of 100. ACS Chemical Neuroscience 2025-06-10 Brain tissue and pathology

    High Resolution Image Download MS PowerPoint Slide Pathological aggregates of TDP-43 are implicated in Alzheimer’s disease, frontotemporal dementia, and amyotrophic lateral sclerosis.

  17. Impact of white matter hyperintensities on α4β2 nicotinic acetylcholine receptor binding in the human brain

    ✓ Peer-reviewed alzhub usefulness score 37 out of 100. European Journal of Nuclear Medicine and Molecular Imaging 2025-06-10 Vascular contributions

    This study shows that WMHs do not significantly alter gray matter nicotinic signaling in directly connected regions.

  18. Targeting NLRP3 signaling with a novel sulfonylurea compound for the treatment of vascular cognitive impairment and dementia

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Fluids and Barriers of the CNS 2025-06-03 Inflammation and the immune system

    AMS-17 treatment improved cognitive function, enhanced blood-brain barrier (BBB) integrity, and promoted remyelination in VaD mice.

  19. Anti-pyroglutamate-3 Aβ immunotherapy engages microglia and inhibits amyloid accumulation in transgenic mouse models of Aβ amyloidosis

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Acta Neuropathologica 2025-06-02 Treatments

    Alzheimer disease (AD) is the most common form of dementia affecting more than 6 million people in the United States.

  20. Lecanemab Binds to Transgenic Mouse Model‐Derived Amyloid‐β Fibril Structures Resembling Alzheimer's Disease Type I, Type II and Arctic Folds

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Neuropathology and Applied Neurobiology 2025-06-01 Treatments

    Our results show that lecanemab exhibits high binding affinity to amyloid-β fibril structures that have a flexible N-terminus in common, as is the case for type I, type II and murine type III amyloid-β fibril polymorphs, which resemble or are identical to human structures observed in sporadic and familial cases of Alzheimer's disease, including a case with the Arctic (E22G) mutation.

  21. TDP-43 dysregulation of polyadenylation site selection is a defining feature of RNA misprocessing in amyotrophic lateral sclerosis and frontotemporal dementia

    ✓ Peer-reviewed alzhub usefulness score 51 out of 100. Journal of Clinical Investigation 2025-06-01 Lewy body dementia

    Nuclear clearance and cytoplasmic aggregation of TAR DNA-binding protein 43 (TDP-43) are observed in many neurodegenerative disorders, including amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).

  22. TDP-43 overexpression in the hypothalamus drives neuropathology, dysregulates metabolism and impairs behavior in mice

    ✓ Peer-reviewed alzhub usefulness score 38 out of 100. Acta Neuropathologica Communications 2025-05-27 Brain tissue and pathology

    TAR DNA-binding protein 43 (TDP-43) pathology is linked to the neurodegenerative disorders amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD) and Huntington disease (HD).

  23. The Role of TDP-43 in SARS-CoV-2-Related Neurodegenerative Changes

    ✓ Peer-reviewed alzhub usefulness score 39 out of 100. Viruses 2025-05-19 Brain tissue and pathology

    The coronavirus disease 2019 (COVID-19) pandemic has been linked to long-term neurological effects with multifaceted complications of neurodegenerative diseases.

  24. Neuroprotective, Antioxidant and Anti-Inflammatory Effect of Greek Pomegranate Seed Oil on N2a Neuroblastoma Cells and Mild Cognitive Impairment Patients

    ✓ Peer-reviewed alzhub usefulness score 35 out of 100. Biology 2025-05-15 Mild cognitive impairment

    Alzheimer’s disease (AD) remains a significant global health challenge with limited FDA-approved treatments, necessitating the search for novel preventive strategies.

  25. Alzheimer’s disease (AD) and related tauopathies such as frontotemporal dementia (FTD) or traumatic brain injury (TBI) are neurodegenerative disorders characterized by progressive loss of memory and cognitive function.

  26. Molecular mechanisms and consequences of TDP-43 phosphorylation in neurodegeneration

    ✓ Peer-reviewed alzhub usefulness score 48 out of 100. Molecular Neurodegeneration 2025-05-08 Brain tissue and pathology

    Increased phosphorylation of TDP-43 is a pathological hallmark of several neurodegenerative disorders, including amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).

  27. Molecular Mechanisms of Protein Aggregation in ALS-FTD: Focus on TDP-43 and Cellular Protective Responses

    ✓ Peer-reviewed alzhub usefulness score 44 out of 100. Cells 2025-05-08 Brain tissue and pathology

    Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD) are two neurodegenerative disorders that share common genes and pathomechanisms and are referred to as the ALS-FTD spectrum.

  28. Microbiota fasting-related changes ameliorate cognitive decline in obesity and boost ex vivo microglial function through the gut-brain axis

    ✓ Peer-reviewed alzhub usefulness score 53 out of 100. Gut 2025-05-07 Prevention trials

    Both the Keto and ADF groups demonstrated significant weight loss, but cognitive performance improved most notably in the ADF group, in association with reduced inflammation.

  29. Neuroimmune signaling mediates astrocytic nucleocytoplasmic disruptions and stress granule formation associated with TDP-43 pathology

    ✓ Peer-reviewed alzhub usefulness score 39 out of 100. Neurobiology of Disease 2025-05-06 Brain tissue and pathology

    Alterations in transactivating response region DNA-binding protein 43 (TDP-43) are prevalent in amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), and other neurological disorders.

  30. One of the major consequences of diabetes mellitus that has gained attention due to its rising incidence is cognitive impairment.

  31. PINK1-dependent NFKB signaling contributes to amyloid pathology in Alzheimer disease

    ✓ Peer-reviewed alzhub usefulness score 42 out of 100. Autophagy 2025-05-04 Disease mechanisms

    Mitochondrial dysfunction plays a preponderant role in the development of Alzheimer disease (AD).

  32. Choroid plexus free‐water correlates with glymphatic function in Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 61 out of 100. Alzheimer s & Dementia 2025-05-01 Disease mechanisms

    At baseline, Aβ+ participants showed higher CP FWf, increased white matter hyperintensity (WMH) volume, and decreased diffusion tensor image analysis along the perivascular space (DTI-ALPS).

  33. Neuroprotective Potential of Tetraselmis chuii Compounds: Insights into Blood–Brain Barrier Permeability and Intestinal Transport

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Pharmaceuticals 2025-04-26 Disease mechanisms

    The results showed that T. chuii extracts could protect neuronal cells from neurotoxic damage, especially against L-glutamate and H2O2.

  34. Presenilin 1 M139I mutation regulates the microRNA-34a-mediated neurogenic locus notch homolog protein 1 signaling pathway in an early-onset Alzheimer disease cell model

    ✓ Peer-reviewed alzhub usefulness score 30 out of 100. Journal of Neuropathology & Experimental Neurology 2025-04-26 Risk genes beyond APOE

    Presenilin 1 (PSEN1) mutations are the leading cause of early-onset Alzheimer disease (EOAD).

  35. TDP-43 seeding activity in the olfactory mucosa of patients with amyotrophic lateral sclerosis

    ✓ Peer-reviewed alzhub usefulness score 46 out of 100. Molecular Neurodegeneration 2025-04-26 Brain tissue and pathology

    TDP-43_SAA was positive in 29/65 patients with sporadic MND, 9/21 patients with genetic MND, 6/17 OND patients and 3/22 controls.

  36. Pathological α-synuclein dysregulates epitranscriptomic writer METTL3 to drive neuroinflammation in microglia

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Cell Reports 2025-04-23 Inflammation and the immune system

    Recent reports suggest dysregulation of the N6-methyladenosine (m6A) RNA modification may contribute to the pathology of neurodegenerative diseases.

  37. Plasma TAR DNA-binding protein 43 (TDP-43) levels in a population-based cohort of older adults: The cardiovascular health study

    ✓ Peer-reviewed alzhub usefulness score 51 out of 100. Journal of Alzheimer s Disease 2025-04-23 Brain tissue and pathology

    Brain deposition of transactive response DNA-binding protein 43 (TDP-43) is a feature of neurodegenerative syndromes.

  38. Amyotrophic lateral sclerosis and frontotemporal dementia mutation reduces endothelial TDP-43 and causes blood-brain barrier defects

    ✓ Peer-reviewed alzhub usefulness score 44 out of 100. Science Advances 2025-04-16 Lewy body dementia

    Mutations in the TARDBP gene encoding TDP-43 protein are linked to loss of function in neurons and familial frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS).

  39. A structural haplotype in the 17q21.31 MAPT region is associated with increased risk for chronic traumatic encephalopathy endophenotypes

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Cell Reports Medicine 2025-04-15 Disease mechanisms

    Chronic traumatic encephalopathy (CTE) is a neurodegenerative tauopathy associated with repetitive head impact (RHI) exposure.

  40. A role for astrocytic miR-129-5p in frontotemporal dementia

    ✓ Peer-reviewed alzhub usefulness score 42 out of 100. Translational Psychiatry 2025-04-11 Lewy body dementia

    Frontotemporal dementia is a debilitating neurodegenerative disorder characterized by frontal and temporal lobe degeneration, resulting in behavioral changes, language difficulties, and cognitive decline.

  41. Natural Products in the Treatment of Neuroinflammation at Microglia: Recent Trend and Features

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Cells 2025-04-10 Inflammation and the immune system

    Natural products (NPs) are considered to be the oldest medicine in human history and numerous NPs have been investigated to search for therapeutic agents in various diseases.

  42. Immune checkpoint TIM-3 regulates microglia and Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 59 out of 100. Nature 2025-04-09 Laboratory science

    Microglia are the resident immune cells in the brain and have pivotal roles in neurodevelopment and neuroinflammation 1,2 .

  43. Membrane Charge Drives the Aggregation of TDP-43 Pathological Fragments

    ✓ Peer-reviewed alzhub usefulness score 45 out of 100. Journal of the American Chemical Society 2025-04-08 Brain tissue and pathology

    TDP-43 protein is an RNA-binding protein linked to amyotrophic lateral sclerosis, frontotemporal dementia, and Alzheimer disease.

  44. We found that ICVIGF-1 administration protected working memory demonstrated as (1) reduced latency to reach the platform, and reduced swimming distance in trials 3 (p < 0.05) and 4 (p < 0.01) on days 45 and 90 post-injection and (2) a short-term (up to 45 days post-injection) enhancement of reference memory, manifested by a reduction in swimming distance and latency (p < 0.05).

  45. Mechanisms of action of formononetin, an extract from Astragalus membranaceus medicinal plant, in ameliorating Alzheimer’s disease

    ✓ Peer-reviewed alzhub usefulness score 34 out of 100. Exploration of neuroscience 2025-04-02 Disease mechanisms

    Alzheimer’s disease (AD), the term “dementia”, describes a specific neuropathology together with the development and progression of age-related cognitive and functional loss.

  46. Genome‐wide association analysis identifies APOE as a mitophagy modifier in Lewy body disease

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Alzheimer s & Dementia 2025-04-01 Lewy body dementia

    We identified a significant genome-wide association with p-S65-Ub for rs429358 (apolipoprotein E ε4 [APOE4]) and a suggestive association for rs6480922 (ZMIZ1).

  47. Seeded aggregation of TDP-43 induces its loss of function and reveals early pathological signatures

    ✓ Peer-reviewed alzhub usefulness score 35 out of 100. Neuron 2025-03-31 Brain tissue and pathology

    Neurodegeneration in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) results from both gain of toxicity and loss of normal function of the RNA-binding protein TDP-43, but their mechanistic connection remains unclear.

  48. Repulsive Guidance Molecule-A as a Therapeutic Target Across Neurological Disorders: An Update

    ✓ Peer-reviewed alzhub usefulness score 40 out of 100. International Journal of Molecular Sciences 2025-03-30 Disease mechanisms

    Repulsive guidance molecule-a (RGMa) has emerged as a significant therapeutic target in a variety of neurological disorders, including neurodegenerative diseases and acute conditions.

  49. A stress-dependent TDP-43 SUMOylation program preserves neuronal function

    ✓ Peer-reviewed alzhub usefulness score 48 out of 100. Molecular Neurodegeneration 2025-03-28 Brain tissue and pathology

    Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD) are overwhelmingly linked to TDP-43 dysfunction.

  50. Semaglutide improves cognitive function and neuroinflammation in APP/PS1 transgenic mice by activating AMPK and inhibiting TLR4/NF-κB pathway

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Journal of Alzheimer s Disease 2025-03-28 Inflammation and the immune system

    BackgroundAlzheimer's disease (AD) causes cognitive function disorder and has become the preeminent cause of dementia.

From across this tag

10 of the 1,153 studies in this tag, picked by a fixed rule (a hash of each study's address), not by score or date; each page of this list shows a different 10. The same 10 appear here every time.

All topic tags with their study counts